Cannabis and Consequences from a Criminal Defense Perspective
Criminal violations, such as driving while intoxicated, probation and loss of employment for a positive drug test are just some of the changes that routinely draw the attention of legal, medical and political pundits.
June 23, 2020 at 12:00 PM
8 minute read
Much has changed over the last decade when it comes to cannabis law. While marijuana possession, sale and manufacture remain technically illegal in New Jersey and Pennsylvania on both the state and federal levels, the states differ on many of the enforcement protocols and penalties. This is particularly true in the area of medical marijuana (MMJ). Laws related to its legal use in New Jersey will continue to evolve.
This past January marked 10 years since Governor Jon Corzine signed the New Jersey Compassionate Use Medical Marijuana Act (N.J.S.A. 24:6I-1 et seq.) into law, making it 14th state to allow medical marijuana. The first Alternative Treatment Center and dispensary opened in December 2012. CUMMA, as it is called, does not allow residents to grow their own marijuana plants. Instead, the state's registry allows physicians to initiate patient certification with the Medical Marijuana Program, and qualified individuals can possess up to two ounces of medical marijuana within a 30-day period.
Marijuana is classified as a Schedule I controlled substance—a category reserved for substances with a high potential for abuse and no generally recognized medical value. The evolution continues, and laws continue to be defined and redefined. Criminal violations, such as driving while intoxicated (DWI), probation and loss of employment for a positive drug test are just some of the changes that routinely draw the attention of legal, medical and political pundits.
Medical Marijuana and DWI
As in most states, New Jersey takes a hard line when it comes to DWI offenses. First time offenders, in the case of alcohol, are subject to license suspension and must install an ignition interlock device in their vehicle. The State also takes a conservative position when it comes to cannabis use, including that of MMJ.
New Jersey Title 39 (NJ Rev Stat §39:4-50) is clear, allowing any amount of marijuana within a person's blood test as evidence of DWI. Further, the law prohibits a person from operating a motor vehicle with marijuana or its chemical components, metabolites (the non-psychoactive compounds produced from psychoactive substances [THC] in the body), present in a person's blood stream despite the legalization of medical marijuana for prescribed use.
One underlying issue is how MMJ interacts within the human body. Unlike alcohol, which is broken down by the body within hours, traces of the non-psychoactive material found in MMJ can stay in one's blood stream for days or weeks depending on an individual's unique physical and physiological characteristics. Just as no two people are the same, MMJ will react differently patient to patient.
Applying this fact to current New Jersey cannabis laws related to DWI creates inconsistent results. Traces of MMJ stay in a person's blood for days and marijuana metabolites can be detected even if someone has not ingested the drug on the same day they are pulled over while operating a motor vehicle. Under the state's current "zero tolerance" approach, that person could still be subject to prosecution even without proof of impaired driving. This is based on marijuana's remaining listed as a Schedule I controlled substance and is consistent with laws in the neighboring Commonwealth of Pennsylvania.
Other states have taken different approaches to medical marijuana and the operation of motor vehicles. Many have taken the position that an individual cannot be prosecuted unless the government can prove driver impairment. There are also several states that have established per se levels of THC (the chemical responsible for the drug's psychoactive effects), similar to how alcohol is treated (.08 blood alcohol content level). However, at this time, the science of establishing per se levels of marijuana intoxication has not yet been established. Other prosecutors look at the totality of circumstances when handling DUI/DWI matters involving cannabis, and base their decisions on a group of impairment issues.
Many predict that states will most likely all move away from a "zero tolerance" position as the science progresses. Law enforcement will rely on physical observations, body cams, dash cams and other technology to prosecute those who would ingest cannabis to the point where they are unable to safely operate a motor vehicle.
Medical Marijuana and Probation
Cannabis Law in New Jersey is a bit more straightforward when it comes to individuals on parole or probation. Specifically, ex-offenders under supervision with a state-issued identification card may use marijuana for prescribed medical use just as with any other valid prescription. Positive test results will not be a violation of either parole or probation. Unlike other states, including Pennsylvania, there is consistency at both the state and county levels.
The fact that New Jersey takes an enlightened approach to MMJ use does not permit a medical marijuana patient to take this as carte blanche to travel with the drug across state lines or assume that others states will honor the New Jersey state-issued MMJ card. Simply put, an arrest for DUI/DWI in another state with zero tolerance could trigger a probation violation in New Jersey. The fact that the state's probation officers have decided to allow MMJ use by probationers does not necessarily bind the other states. An out of state arrest even for medical marijuana users could trigger a probation violation.
Employment and Medical Marijuana
Like many states across the country, New Jersey has afforded both employees and applicants certain job protections if they are legally prescribed MMJ for approved medical use. These were most recently expanded in July 2019 when Governor Phil Murphy signed the Jake Honig Compassionate Use Medical Marijuana Act. Not only did this amendment to the New Jersey CUMMA address how patients "qualify for, purchase and consume cannabis for medicinal purposes," it spoke directly to matters of employment. The act added language explicitly preventing someone from being fired merely based on MMJ use.
In Justin Wild v. Carriage Funeral Holdings d/b/a Feeny Funeral Home (Docket No. A-3072-17T3), the employee, who was prescribed medical marijuana to treat cancer, had been fired after failing an employer-requested drug test—something that can be a result of the very nature of MMJ and how long traces may appear in one's blood system. The plaintiff claimed discrimination as he was legally prescribed and allowed to use medical marijuana outside the workplace by the Compassionate Use Act.
The case was dismissed by the state Superior Court and overruled by the Appellate Division before the New Jersey Supreme Court reaffirmed the lower court ruling that patients approved for MMJ use under the state's program are protected by the Law Against Discrimination, as long as they are not under the influence at work. The decision has been applauded by many as it also ensures consistency between the state's Compassionate Use Act and its Law Against Discrimination.
The Compassionate Use Act further addresses other key questions in matters of employment and cannabis use. Employees and applicants may be subjected to employer drug tests according to state law, but it is not without specific obligations on behalf of the employer. For any positive result, employers must provide written notification and the employee the opportunity to present a medical explanation within three working days. This includes authorization by a health care provider or Cannabis Regulatory Commission registration. Employers must further allow for confirmatory re-testing at the employee's or applicant's expense within the same three-day period.
While employers are now limited in having a "zero tolerance" drug policy, it is not a "free for all" in the workplace. Employers can maintain and act on guidelines that restrict possession or use during work hours and on workplace premises.
Looking Ahead
In closing, there is one constant: More change is on the way. The first four short years have proven that already. Expert opinions vary and include the possible removal of marijuana as a Schedule I controlled substance due to its medicinal value. Another is the question of addiction and balancing the potential dangers. Keeping up to date during the on-going evolution will be important to the legal community and public.
On Nov, 3, 2020, the voting public will have an opportunity to vote on recreational marijuana. In the interim, a decriminalization bill is pending in the State Legislature allowing for possession of up to a pound of marijuana without threat of arrest. Experts predict recreational marijuana will pass in the November election. In the meantime, decriminalization is an important first step.
Marc Neff is is a criminal defense attorney and managing partner of Neff & Sedacca, P.C. in Mount Laurel. Matthew Sedacca is a criminal defense attorney and partner at the firm.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllLaw Firms Look to Gen Z for AI Skills, as 'Data Becomes the Oil of Legal'
Trending Stories
- 1Which Legal Tech Jobs Are on the Rise, and Which Aren't, with Jared Coseglia
- 2Absent Explicit Agreement, Court Rejects Unilateral Responsiveness Redaction of Text Messages
- 3SEC Whistleblower Program: What to Expect Under the Trump Administration
- 4Sidley Hires Paul Hastings Energy Finance Partner in Houston
- 5Potential Pitfalls in Arbitrating Religious Disputes
Who Got The Work
J. Brugh Lower of Gibbons has entered an appearance for industrial equipment supplier Devco Corporation in a pending trademark infringement lawsuit. The suit, accusing the defendant of selling knock-off Graco products, was filed Dec. 18 in New Jersey District Court by Rivkin Radler on behalf of Graco Inc. and Graco Minnesota. The case, assigned to U.S. District Judge Zahid N. Quraishi, is 3:24-cv-11294, Graco Inc. et al v. Devco Corporation.
Who Got The Work
Rebecca Maller-Stein and Kent A. Yalowitz of Arnold & Porter Kaye Scholer have entered their appearances for Hanaco Venture Capital and its executives, Lior Prosor and David Frankel, in a pending securities lawsuit. The action, filed on Dec. 24 in New York Southern District Court by Zell, Aron & Co. on behalf of Goldeneye Advisors, accuses the defendants of negligently and fraudulently managing the plaintiff's $1 million investment. The case, assigned to U.S. District Judge Vernon S. Broderick, is 1:24-cv-09918, Goldeneye Advisors, LLC v. Hanaco Venture Capital, Ltd. et al.
Who Got The Work
Attorneys from A&O Shearman has stepped in as defense counsel for Toronto-Dominion Bank and other defendants in a pending securities class action. The suit, filed Dec. 11 in New York Southern District Court by Bleichmar Fonti & Auld, accuses the defendants of concealing the bank's 'pervasive' deficiencies in regards to its compliance with the Bank Secrecy Act and the quality of its anti-money laundering controls. The case, assigned to U.S. District Judge Arun Subramanian, is 1:24-cv-09445, Gonzalez v. The Toronto-Dominion Bank et al.
Who Got The Work
Crown Castle International, a Pennsylvania company providing shared communications infrastructure, has turned to Luke D. Wolf of Gordon Rees Scully Mansukhani to fend off a pending breach-of-contract lawsuit. The court action, filed Nov. 25 in Michigan Eastern District Court by Hooper Hathaway PC on behalf of The Town Residences LLC, accuses Crown Castle of failing to transfer approximately $30,000 in utility payments from T-Mobile in breach of a roof-top lease and assignment agreement. The case, assigned to U.S. District Judge Susan K. Declercq, is 2:24-cv-13131, The Town Residences LLC v. T-Mobile US, Inc. et al.
Who Got The Work
Wilfred P. Coronato and Daniel M. Schwartz of McCarter & English have stepped in as defense counsel to Electrolux Home Products Inc. in a pending product liability lawsuit. The court action, filed Nov. 26 in New York Eastern District Court by Poulos Lopiccolo PC and Nagel Rice LLP on behalf of David Stern, alleges that the defendant's refrigerators’ drawers and shelving repeatedly break and fall apart within months after purchase. The case, assigned to U.S. District Judge Joan M. Azrack, is 2:24-cv-08204, Stern v. Electrolux Home Products, Inc.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250